Supplier profile
Contact details
Phidea was founded in Milan in 1982, as a Drug Development Company, and in 1991 the Spanish subsidiary, based in Madrid, started its activities.
Since its foundation Phidea has built a broad know how in global product development, starting its involvement after the definition of the chemical entity of the active pharmaceutical ingredient, and bringing it to registration and supporting its commercialisation.
Phidea can follow all the development thanks to the strong partnerships created with Companies specialised in each step of drug development, and directly working in clinical development.
Phideas services start with the identification of patent strategy, followed by the coordination of the activities of the Partners involved both in pharmaceutical formulation definition, stability t ...rials, first experimental batch production, and in design and conduct of the pharmacological/toxicological development plan.
Through the years Phidea specialised in Clinical Development, managing directly in all Europe multinational pre registration clinical trials (phase I-Phase III), post marketing clinical trials (Phase IV), as well as epidemiological and observational studies (mega trials). Thanks to this broad range of activities Phidea may now offer its support in all product life cycle.
Today Phidea is the ideal partner of those Companies that for any reason need to outsource the development of a specific drug from patent submission to registration in Europe. Read more
Since its foundation Phidea has built a broad know how in global product development, starting its involvement after the definition of the chemical entity of the active pharmaceutical ingredient, and bringing it to registration and supporting its commercialisation.
Phidea can follow all the development thanks to the strong partnerships created with Companies specialised in each step of drug development, and directly working in clinical development.
Phideas services start with the identification of patent strategy, followed by the coordination of the activities of the Partners involved both in pharmaceutical formulation definition, stability t ...rials, first experimental batch production, and in design and conduct of the pharmacological/toxicological development plan.
Through the years Phidea specialised in Clinical Development, managing directly in all Europe multinational pre registration clinical trials (phase I-Phase III), post marketing clinical trials (Phase IV), as well as epidemiological and observational studies (mega trials). Thanks to this broad range of activities Phidea may now offer its support in all product life cycle.
Today Phidea is the ideal partner of those Companies that for any reason need to outsource the development of a specific drug from patent submission to registration in Europe. Read more
Categoria
- Ricerca farmaceutica